Xtant Medical Holdings, Inc.
XTNT
$0.51
$0.0234.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2,592.27% | -738.60% | 62.25% | 80.10% | 107.78% |
| Total Depreciation and Amortization | 33.08% | 65.17% | 98.42% | 150.20% | 145.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 158.45% | 156.07% | -306.68% | -310.52% | -308.34% |
| Change in Net Operating Assets | -47.19% | 12.60% | -17.15% | -39.40% | -29.28% |
| Cash from Operations | -25.02% | -23.77% | -71.00% | -97.89% | -78.15% |
| Capital Expenditure | -182.49% | -147.66% | -5.43% | -2.13% | 17.46% |
| Sale of Property, Plant, and Equipment | 118.86% | 320.88% | 218.95% | 62.59% | -14.63% |
| Cash Acquisitions | -- | 90.42% | 61.75% | 61.75% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 84.95% | 76.08% | 56.63% | 56.76% | -1,489.74% |
| Total Debt Issued | 41.36% | 46.92% | 54.57% | 45.36% | 53.46% |
| Total Debt Repaid | -36.56% | -44.98% | -51.13% | -43.84% | -41.30% |
| Issuance of Common Stock | -68.10% | -73.68% | 50.48% | 50.48% | 50.48% |
| Repurchase of Common Stock | 31.80% | -111.76% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -172.38% | -- | -645.54% | -1,487.50% | -- |
| Cash from Financing | -18.37% | -30.94% | 60.42% | 49.16% | 118.30% |
| Foreign Exchange rate Adjustments | -720.83% | 169.81% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.04% | 81.22% | 108.31% | 93.20% | -787.92% |
